Stocktoria
Avantor, Inc. AVTR
Avantor, Inc. (AVTR) earns a Piotroski F-score of 4/9 (mixed financial health), with an Altman Z″ in the grey zone. It does not currently pay a dividend. FY2025 revenue was $6.6B at a -8.1% net margin.
Quality score trend · recomputed for each fiscal year
Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.
Beneish M-score: -2.91 — low (below −2.22 — no manipulation red flag) . A statistical screen for earnings manipulation, not proof — and it doesn't apply to most banks/insurers.
Analyst price target
Recent analyst actions
| Date | Firm | Rating |
|---|---|---|
| 2026-06-24 | Barclays | Underweight (main) |
| 2026-04-30 | Citigroup | Neutral (main) |
| 2026-04-30 | Evercore ISI Group | In-Line (main) |
| 2026-04-15 | Barclays | Underweight (main) |
| 2026-04-06 | Evercore ISI Group | In-Line (main) |
| 2026-03-06 | Barclays | Underweight (down) |
Wall Street analyst consensus — a sentiment gauge, not our scoring.
How it ranks in Manufacturing · percentile among 1957 companies
Percentile vs other Manufacturing companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 4/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″ components · grey zone
| Component | Value |
|---|---|
| Working capital / assets | 0.091 |
| Retained earnings / assets | 0.142 |
| EBIT / assets | -0.021 |
| Equity / liabilities | 0.893 |
Sector peers · similar-size Manufacturing companies compare side by side →
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| AVTR | Avantor, Inc. | 4/9 | 1.86 | — | -3.4% |
| A | AGILENT TECHNOLOGIES, INC. | 5/9 | 3.48 | 29.5 | +6.7% |
| ILMN | ILLUMINA, INC. | 7/9 | 3.04 | 31.4 | -0.7% |
| MTD | METTLER TOLEDO INTERNATIONAL INC/ | 5/9 | — | 29.4 | +4% |
| BRKR | BRUKER CORP | 4/9 | 2.98 | — | +2.1% |
| WAT | WATERS CORP /DE/ | 4/9 | 10 | 55.1 | +7% |
| RVTY | REVVITY, INC. | 6/9 | 3.86 | 52.3 | +3.7% |
About Avantor, Inc.
Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, peristaltic pumps, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Further, it provides scientific research support services, such as DNA extraction, bioreactor servicing, clinical and biorepository, compound management, cleanroom control, monitoring, maintenance, and sanitization services. The company was founded in 1904 and is headquartered in Radnor, Pennsylvania.
FAQ
Is AVTR financially healthy?
Avantor, Inc.'s Piotroski F-score is 4/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the grey zone.
Does AVTR pay a dividend?
No, Avantor, Inc. does not currently pay a dividend.
How profitable is AVTR?
In FY2025, Avantor, Inc. had a net margin of -8.1% and a return on equity of -9.5%.
Is AVTR overvalued or undervalued?
Avantor, Inc. trades at about 13.4× trailing earnings — below its 10-year norm (10-year range 21.4×–327.7×, median 43.9×). Stocktoria reports the data, not buy/sell advice.
What is the analyst price target for AVTR?
The average Wall-Street price target for Avantor, Inc. is $9.78, about 29.8% below the recent price, from 16 analysts (consensus: hold).
Is AVTR a good stock to buy?
Stocktoria doesn't give buy or sell advice, but here is the data on Avantor, Inc.: a Piotroski F-score of 4/9, an Altman Z″ in the grey zone. Weigh these quality and valuation signals against your own goals.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.